Known targets — ChEMBL curated mechanism
AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA
The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL5248436 | 0.98 | ALDH1A1 (0.41) | ALDH1A1KDM4ECA12CA1CA2 | |
| Water SCHEMBL4269781 | 0.98 | ALDH1A1 (0.41) | ALDH1A1KDM4ECA12CA1CA2 | |
| SCHEMBL3717130 | 0.96 | ALDH1A1 (0.42) | ALDH1A1KDM4ECA12CA1CA2 | |
| SCHEMBL229142 | 0.96 | ALDH1A1 (0.42) | ALDH1A1KDM4ECA12CA1CA2 | |
| SCHEMBL3904265 | 0.96 | ALDH1A1 (0.42) | ALDH1A1KDM4ECA12CA1CA2 | |
| SCHEMBL3365753 | 0.96 | ALDH1A1 (0.42) | ALDH1A1KDM4ECA12CA1CA2 | |
| SCHEMBL14894927 | 0.96 | ALDH1A1 (0.42) | ALDH1A1KDM4ECA12CA1CA2 | |
| SCHEMBL29552462 | 0.96 | ALDH1A1 (0.42) | ALDH1A1KDM4ECA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL23532725 | 0.94 | ALDH1A1 (0.41) | ALDH1A1KDM4ECA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL20536266 | 0.94 | ALDH1A1 (0.41) | ALDH1A1KDM4ECA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117158410-A | Method for cryopreserving oocytes of Erythroculter mongolica | 上海海洋大学 | 2023-12-05 | — | — | CN | claimed |
| EP-4087589-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER NEURODEGENERATIVE DISEASES | The Sallie Astor Burdine Breast Foundation (US) | 2022-11-16 | — | — | EP | claimed |
| CN-115003313-A | Compositions and methods for treating Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases, and related methods for making the compositions | 萨莉阿斯特伯丁乳腺癌基金会 | 2022-09-02 | — | — | CN | claimed |
| US-10107736-B2 | Hydrogel compositions and methods for electrochemical sensing | PORTLAND STATE UNIVERSITY (US) | 2018-10-23 | — | — | US | claimed |
| US-20160123865-A1 | HYDROGEL COMPOSITIONS AND METHODS FOR ELECTROCHEMICAL SENSING | PORTLAND STATE UNIVERSITY (US) | 2016-05-05 | — | — | US | claimed |
| US-20140273458-A1 | Chemical Mechanical Planarization for Tungsten-Containing Substrates | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-09-18 | — | — | US | claimed |
| EP-2779217-A2 | Chemical mechanical planarization for tungsten-containing substrates | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-09-17 | — | — | EP | claimed |
| CN-104046246-A | Chemical Mechanical Planarization for Tungsten-Containing Substrates | AIR PROD & CHEM | 2014-09-17 | — | — | CN | claimed |
| EP-3924504-B1 | HAPLOTAGGING - SINGLE TUBE COMBINATORIAL BARCODING OF NUCLEIC ACID MOLECULES | MAX PLANCK GESELLSCHAFT (DE) | 2026-05-27 | — | — | EP | disclosed |
| US-20260083781-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF TRAUMATIC BRAIN INJURY (TBI), FOR EXAMPLE, MILD TRAUMATIC BRAIN INJURY (mTBI) | THE SALLIE ASTOR BURDINE BREAST FOUND (US) | 2026-03-26 | — | — | US | disclosed |
| EP-3715462-B1 | METHOD FOR REGULATING IN VITRO BIOSYNTHESIS ACTIVITY BY KNOCKING-OUT OF NUCLEASE SYSTEM | KANGMA HEALTHCODE SHANGHAI BIOTECH CO LTD (CN) | 2026-03-25 | — | — | EP | disclosed |
| US-12578305-B2 | Photoswitchable binary nanopore capable of detecting single molecules | UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES (US) | 2026-03-17 | — | — | US | disclosed |
| US-20250354285-A1 | ELECTROCHEMICAL METAL DEPOSITION SYSTEM AND METHOD | Nth Cycle, Inc. (US) | 2025-11-20 | — | — | US | disclosed |
| US-20250312380-A1 | COMPOSITIONS AND METHODS FOR ISOLATION OF MITOCHONDRIA FROM CRYOPRESERVED CELLS | The Sallie A. Burdine Breast Foundation | 2025-10-09 | — | — | US | disclosed |
| US-5480772-A | SEPARATION OF NUCLEUS FROM ERYTHROCYTES USING PROTEASE AND NONIONIC DETERGENTS, CONTACTING WITH CYTOSTATIC FACTOR EXTRACT AND PRETREATMENT WITH ACTIVATING EGG EXTRACT | BRANDEIS UNIVERSITY (US) | 1996-01-02 | — | — | US | disclosed |
| EP-0686202-A1 | PRENATAL SCREENING | BRANDEIS UNIVERSITY (US) | 1995-12-13 | — | — | EP | disclosed |
| WO-1994028886-A1 | USE OF NATURAL PRODUCTS AND RELATED SYNTHETIC COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE | THE UNIVERSITY OF SYDNEY (AU) | 1994-12-22 | — | — | WO | disclosed |
| WO-1994018344-A1 | PRENATAL SCREENING | BRANDEIS UNIVERSITY (US) | 1994-08-18 | — | — | WO | disclosed |
| US-4649107-A | Phenylethanolamine N-methyltransferase based radioenzymatic assay for norephinephrine | ELI LILLY AND COMPANY (US) | 1987-03-10 | — | — | US | disclosed |
| US-4582806-A | RADIOENZYMATIC ASSAYS OF ENDOGENOUS COMPOUNDS | ELI LILLY AND COMPANY (US) | 1986-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083781-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF TRAUMATIC BRAIN INJURY (TBI), FOR EXAMPLE, MILD TRAUMATIC BRAIN INJURY (mTBI) | HSPA9, TIMM9, ACAD9 | ALDH1A1 2881/4885KDM4E 2874/4885CA12 2413/4885 |
| US-12578305-B2 | Photoswitchable binary nanopore capable of detecting single molecules | EPCAM, TSPO, CD44 | ALDH1A1 4071/4885KDM4E 4204/4885CA12 857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.